Oxazolidinones for the treatment and/or prophylaxis of heart failure

Details for Australian Patent Application No. 2008335922 (hide)

Owner Janssen Pharmaceutica N.V. Bayer Schering Pharma Aktiengesellschaft

Inventors Thielemann, Wolfgang; Kallabis, Harald; Kubitza, Dagmar; Rohrig, Susanne; Mahal, Jeet; Spiro, Theodore; Haskell, Lloyd; Perzborn, Elisabeth

Agent Davies Collison Cave

Pub. Number AU-A-2008335922

PCT Pub. Number WO2009/074249

Priority 61/007,406 11.12.07 US

Filing date 3 December 2008

Wipo publication date 18 June 2009

International Classifications

A61K 31/5377 (2006.01)

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

3 June 2010 PCT application entered the National Phase

  PCT publication WO2009/074249 Priority application(s): WO2009/074249

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008335930-Oxidative stabilizing of sterols and sterol esters

2008335916-Casing expanding tool